P1

The Potential of Two Non-Vaginal Routes of Misoprostol Administration Following Mifepristone for Medical Abortion Up to 63 Days Gestation

P2

Ability of Endometrial Thickness Following Medical Abortion to Predict Subsequent Surgical Intervention

P3

Serum Levels of Doxycycline at the Time of Dilation and Evacuation With Two Dosing Regimens

P4

Accuracy of Abdominal Ultrasonography in Determining Gestational Age and Outcomes in Early Medical Abortion

P5

Medical Abortion Outcomes after a Second-Dose of Misoprostol: Is the Presence of Cardiac Motion on Follow-Up Ultrasonography Predictive of Failure?

P6

Outcome of Medical Abortion Through 63 Days in Women With Prior Cesarean Section

P7

Misoprostol for Treatment of Early Pregnancy Failure in Women with Prior Uterine Surgery

P8

Predictors of Pain and Bleeding in Medical Abortion

P9

Predictors of Dilation and Curettage After Medical Abortion Through 63 Days Gestation

P10

The Provision of Medical Abortifacients by Pharmacies in Morelos, Mexico

P11

Eliciting Women’s Preferences in Medical Abortion Treatment Using Willingness to Pay

P12

Misoprostol Inhibits Innate Immune Defenses Against Clostridium Sordellii In Vitro

P13

Decreased Waiting Periods in a Public Pregnancy Termination Clinic

P14

Overcoming Barriers to offering Abortion Care in Family Medicine

P15

Incarcerated Women and Abortion Provision: A Survey of Services in Correctional Health Facilities

P16

African American Girls Views and Attitudes towards Abortion

P17

Emotional Prophylaxis for Abortion Patients: A Pilot Study

P18

Sex Selective Abortions Leading to Skewed Child Sex Ratio in An Urban Locality of East Delhi

P19

Prevalence of Chlamydia and Gonorrhea in a Public Pregnancy Termination Clinic

P20

HIV Testing Pregnant Women in Washington State

P21

A Nurse Directed Intervention Focusing On The Prevention of Sexually Transmitted Infections in African-American Women

P22

Sex, that Act, Intercourse, Doing It: The Language of Sexual Health in E-Mails to the Emergency Contraception Website

P23

There’s Always Plan B: Adolescent Knowledge, Attitudes and Intention to Use Emergency Contraception

P24

Emergency Contraception: Barrier Or Bridge to Effective Contraception?

P25

Access to Emergency Contraception on U.S. College Campuses

P26

Statewide EC Availability in Nebraska

P27

Emergency Contraception in Palestine: Assessing Retail Pharmacists’ Awareness, Opinions and Perceptions of Need

P28

An Animal Model of Uterine Auto and Allo-Transplantation With a Successful Pregnancy

P29

Intimate Partner Violence in Postpartum Women

P30

The Prevalence of Domestic Violence in Women Who Volunteer for Gynecologic Research Studies

P31

Prevalence and Social Correlates of Domestic Violence During Pregnancy; Evidence From a Lower Income Country

P32

Reproductive Health Issues in Women with Cancer: A Case Series Study

P33

Computerized Counseling About Folate: A Randomized Trial

P34

Evaluation of Sudanese Womens’ Sexual Life After Childbirth

P35

Strategies in Addressing Hispanic Reproductive Health

P36

Chronic Endometritis in Depot Medroxy-progesterone Acetate Users: Is Chlamydia Trachomatis a Cause?

P37

Depo Medroxyprogesterone Acetate (Dmpa) Use in Obese and Morbidly Obese Women: Incidence of Ovulation

P38

Effectiveness and Safety of the New Contraceptive: One Rode Implant – Implanon

P39

Increasing Utilization and Patterns of Use of The Levonorgestrel Intrauterine System – Data From a Large U.S. Health Plan

P40

Bleeding Patterns in Users of a 91-DAY Extended Regimen Oral Contraceptive with Low Dose Estrogen in a Place of Placebo Compared to a Conventional 28-Day Regimen

P41

Evaluation of 91-Day Extended Regimen Oral Contraceptive Continuation

P42

Evaluation of The Long-Term Safety of a 91-Day Extended Regimen Oral Contraceptive With Low-Dose Estrogen in Place of Placebo.

P43

Vaginal Ring Versus Combined Oral Contraceptives for Contraception: A Systematic Review

P44

Contraceptive Discontinuation Due to Method Dissatisfaction in the United States

P45

Medical Student Misinformation and Bias Regarding Elective Pregnancy Termination

P46

Does Vasectomy Explain the Difference in Tubal Sterilization Rates Between Black and White Women?

P47

Race and Desire for Tubal Sterilization Reversal

P48

FHI’s Decision to Halt Development of Quinacrine: Why and How

P49

Development of a Contraceptive Survey to Be Used in a Computerized tool Providing Personalized Output

P50

Clustering of Adolescent Females Seeking Family Planning Services at an Urban Clinic: Differences in Pregnancy Outcomes After One Year

P51

Contraceptive Preferences of Adolescent Mothers

P52

Perceptions of Oral Contraception Safety and Interest in Over-The-Counter Access Among a Predominantly Latina Population in Texas

P53

Health System Reforms to Promote Intra Uterine Device as a Spacing Method in India

P54

Refugee Family Planning: User Profiles From Mtendeli Refugee Camp in Kibondo, Tanzania

P55

Regional Quality Indicators Project-Journey into Quality Assurance: Pilot Phase through First Year of Data Collection and Reporting 1999-2005

P56

Understanding Trends and Factors that Influence Use of Withdrawal Among Hispanic, White and African American Women and Adolescents

P57

Unintended Pregnancy Has Measurable Effects on Women's Quality of Life

P58

Public and Private Providers Provision of Services, Their Views On The Problems Patients Have Using Contraception and Steps Needed to Improve Use

P59

Designing a Culturally Appropriate Family Planning Program: The Somali Child Spacing Project

P60

Pills, Dmpa, Sterilization and The Sdm: What Simulated Clients Tell Us About Provider Competence and Bias

P61

The Association of Body Mass Index and Unintended Pregnancy in the US: Results From Cycle 6 of The National Survey of Family Growth

P62

Unmet Family Planning Need Among U.S. Men